Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 7/16/15  and contains information from public web pages and contributions from the ZoomInfo community.

Prof. Mark Kirkland

Wrong Prof. Mark Kirkland?

Medical Director

Cell Care Research
Phone: +61 **** *** ***  HQ Phone
Local Address:  Melbourne , Victoria , Australia
Cell Care
P.O. Box 833
Moorabbin , Victoria 3189
Australia

Company Description: Cell Care is committed to making a meaningful impact on the health of Australians. We will achieve this by being Australia's leading family cord blood and cord...   more
Background

Employment History

Board Memberships and Affiliations

Education

  • PhD
  • PhD
    Flinders Medical Centre
144 Total References
Web References
The company was founded in 2007 ...
cytomatrix.com.au [cached]
The company was founded in 2007 by Associate Professor Mark Kirkland, who is also the Medical Director of the successful cord blood banking business Cell Care and Associate Professor at Deakin University. he global market across cord blood transplant, bone marrow transplants and high dose chemotherapy patients is estimated to be in excess of USD $4 billion.
...
Mark Kirkland, Chief Scientific Officer
About cord blood banking
www.kidspot.com.au [cached]
The cells can be frozen indefinitely, says Associate Professor Mark Kirkland, medical director of Australia's largest private cord blood bank, Cell Care.
"Tests so far indicate that cells remain the same as when they were first frozen after 23 to 24 years, so as far as we know it's indefinite," he says.
Reasons for banking cord blood include having a family history of disease, or having a baby of an ethnic minority or mixed ethnicity where it may be difficult to find a suitable donor. Currently, more than 41,000 Australians have banked their cord blood.
"Around 1 per cent of mums currently choose to store their baby's cord blood, which is very low," says Professor Kirkland.
...
For future uses, it would be around one in 200," says Professor Kirkland.
...
Professor Kirkland says that if couples don't bank privately then he does encourage public banking, however there are limitations.
"The worst thing is to throw it away, however the availability of public banking is very limited," he explains.
...
And for a lot of these new treatments for diabetes and cerebral palsy the requirement is for the child's own cord blood to be used," adds Professor Kirkland.
Associate Professor Mark ...
www.cellcare.com.au [cached]
Associate Professor Mark Kirkland - Medical Director
Mark is Associate Professor at the Institute of Technology, Research and Innovation at Deakin University.
He is a specialist haematologist with more than 25 years research experience in the field of haemopoietic stem cell biology and 15 years' experience as a clinical and laboratory haematologist.
A former Medical Director of Research for the Australian Red Cross Blood Service in Victoria, he has extensive experience in blood and tissue banking, both public and private cord blood banking, and bone banking.
He was also a member of the committee that developed the Australian (NPAAC) Guidelines for Haemopoietic Stem Cells.
Mark is the Chief Scientific Officer of Cytomatrix Pty Ltd, a biotechnology company specialising in novel technologies for the growth and expansion of cord blood stem cells.
...
Associate Professor Kirkland has been instrumental in the design and development of Cell Care's Clinical Trial program, and in particular has instigated the proposed Australia-wide trial in the use of cord blood to prevent the progression of type 1 diabetes.
Directors & Management Team | Cell Care
www.cellcare.com.au [cached]
Mark Kirkland - Medical Director
...
Mark Kirkland
Email: .(JavaScript must be enabled to view this email address)
Biography
Mark Kirkland is Associate Professor at the Institute of Technology, Research and Innovation at Deakin University.
He is a specialist haematologist with more than 25 years research experience in the field of haemopoietic stem cell biology and 15 years experience as a clinical and laboratory haematologist.
A former Medical Director of Research for the Australian Red Cross Blood Service in Victoria, he has extensive experience in tissue banking, both public and private cord blood banking, and bone banking.
He was also a member of the committee that developed the Australian (NPAAC) Guidelines for Haemopoietic Stem Cells.
He is the Chief Scientific Officer of Cytomatrix Pty Ltd, a biotechnology company specialising in novel technologies for the growth and expansion of human adult stem cells.
...
Prof. Kirkland has been instrumental in the design and development of Cell Care's Clinical Trial program, and in particular has instigated the proposed Australia-wide trial in the use of cord blood to prevent the progression of type 1 diabetes.
...
Professor Mark Kirkland
Mark Kirkland - Medical ...
www.cellcare.com.au [cached]
Mark Kirkland - Medical Director
...
Mark Kirkland
Email: .(JavaScript must be enabled to view this email address)
Biography
Mark Kirkland is Associate Professor at the Institute of Technology, Research and Innovation at Deakin University.
He is a specialist haematologist with more than 25 years research experience in the field of haemopoietic stem cell biology and 15 years experience as a clinical and laboratory haematologist.
A former Medical Director of Research for the Australian Red Cross Blood Service in Victoria, he has extensive experience in tissue banking, both public and private cord blood banking, and bone banking.
He was also a member of the committee that developed the Australian (NPAAC) Guidelines for Haemopoietic Stem Cells.
He is the Chief Scientific Officer of Cytomatrix Pty Ltd, a biotechnology company specialising in novel technologies for the growth and expansion of human adult stem cells.
...
Prof. Kirkland has been instrumental in the design and development of Cell Care's Clinical Trial program, and in particular has instigated the proposed Australia-wide trial in the use of cord blood to prevent the progression of type 1 diabetes.
...
Professor Mark Kirkland
Other People with the name "Kirkland":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304